IL-6 as a keystone cytokine in health and disease
- PMID: 25898198
- DOI: 10.1038/ni.3153
IL-6 as a keystone cytokine in health and disease
Erratum in
-
Corrigendum: IL-6 as a keystone cytokine in health and disease.Nat Immunol. 2017 Oct 18;18(11):1271. doi: 10.1038/ni1117-1271b. Nat Immunol. 2017. PMID: 29044237
Abstract
Interleukin 6 (IL-6) has a broad effect on cells of the immune system and those not of the immune system and often displays hormone-like characteristics that affect homeostatic processes. IL-6 has context-dependent pro- and anti-inflammatory properties and is now regarded as a prominent target for clinical intervention. However, the signaling cassette that controls the activity of IL-6 is complicated, and distinct intervention strategies can inhibit this pathway. Clinical experience with antagonists of IL-6 has raised new questions about how and when to block this cytokine to improve disease outcome and patient wellbeing. Here we discuss the effect of IL-6 on innate and adaptive immunity and the possible advantages of various antagonists of IL-6 and consider how the immunobiology of IL-6 may inform clinical decisions.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials